Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on January 30, 2003

Arteriosclerosis, Thrombosis, and Vascular Biology. 2003
Published online before print January 30, 2003, doi: 10.1161/01.ATV.0000059385.95664.4D
A more recent version of this article appeared on March 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/3/468    most recent
01.ATV.0000059385.95664.4Dv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenblat, M.
Right arrow Articles by Aviram, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenblat, M.
Right arrow Articles by Aviram, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Related Collections
Right arrow Gene expression
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress

Submitted on October 16, 2002
Accepted on January 8, 2003

Mouse Macrophage Paraoxonase 2 Activity Is Increased Whereas Cellular Paraoxonase 3 Activity Is Decreased Under Oxidative Stress

Mira Rosenblat ; Dragomir Draganov ; Catherine E. Watson ; Charles L. Bisgaier ; Bert N. La Du ; and Michael Aviram *

From the Lipid Research Laboratory (M.R., M.A.), Technion Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences and Rambam Medical Center, Haifa, Israel; Department of Pharmacology (D.D., B.N.L.), University of Michigan, Ann Arbor, Mich; and Esperion Therapeutics, Inc (C.E.W., C.L.B.), Ann Arbor, Mich.

* To whom correspondence should be addressed. E-mail: aviram{at}tx.technion.ac.il.

Objective--To determine whether paraoxonases (PONs) are expressed in macrophages and to analyze the oxidative stress effect on their expression and activities.

Methods and Results--We demonstrated the presence (mRNA, protein, activity) of PON2 and PON3 but not PON1 in murine macrophages, whereas in human macrophages, only PON2 was expressed. Under oxidative stress as present in mouse peritoneal macrophages (MPMs) from apoE-deficient (E0) mice as well as in C57BL6 mice, MPMs that were incubated with buthionine sulfoximine, with angiotensin II, with 7-ketocholesterol, or with oxidized phosphatidylcholine, PON2 mRNA levels and lactonase activity toward dihydrocoumarin significantly increased (by 50% to 130%). In contrast, PON3 lactonase activity toward lovastatin was markedly reduced (by 29% to 57%) compared with control cells. The supplementation of E0 mice with dietary antioxidants (vitamin E, pomegranate juice) significantly increased macrophage PON3 activity (by 23% to 40%), suggesting that oxidative stress was the cause for the reduced macrophage PON3 activity. Incubation of purified PON2 or PON3 with E0 mice MPMs resulted in reduced cellular lipid peroxides content by 14% to 19% and inhibition of cell-mediated LDL oxidation by 32% to 39%.

Conclusions--Increased macrophage PON2 expression under oxidative stress could represent a selective cellular response to reduce oxidative burden, which may lead to attenuation of macrophage foam cell formation.


Key words: macrophages • oxidative stress • paraoxonase




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
R. Romani, G. E. De Medio, S. di Tullio, R. Lapalombella, I. Pirisinu, V. Margonato, A. Veicsteinas, M. Marini, and G. Rosi
Modulation of paraoxonase 1 and 3 expression after moderate exercise training in the rat
J. Lipid Res., October 1, 2009; 50(10): 2036 - 2045.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Rosenblat, R. Coleman, S. T. Reddy, and M. Aviram
Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1
J. Lipid Res., May 1, 2009; 50(5): 870 - 879.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Fuhrman, J. Khateeb, M. Shiner, O. Nitzan, R. Karry, N. Volkova, and M. Aviram
Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism
Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1361 - 1367.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. F. Teiber, S. Horke, D. C. Haines, P. K. Chowdhary, J. Xiao, G. L. Kramer, R. W. Haley, and D. I. Draganov
Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N-(3-Oxododecanoyl)-L-Homoserine Lactone
Infect. Immun., June 1, 2008; 76(6): 2512 - 2519.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Fortunato, M. D. Di Taranto, U. M. Bracale, L. Del Guercio, F. Carbone, C. Mazzaccara, A. Morgante, F. P. D'Armiento, M. D'Armiento, M. Porcellini, et al.
Decreased Paraoxonase-2 Expression in Human Carotids During the Progression of Atherosclerosis
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 594 - 600.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. Levy, K. Trudel, M. Bendayan, E. Seidman, E. Delvin, M. Elchebly, J.-C. Lavoie, L.-P. Precourt, D. Amre, and D. Sinnett
Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats
Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1252 - G1261.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. J. Ng, N. Bourquard, S. Y. Hama, D. Shih, V. R. Grijalva, M. Navab, A. M. Fogelman, and S. T. Reddy
Adenovirus-Mediated Expression of Human Paraoxonase 3 Protects Against the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1368 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. I. Draganov
Human PON3, Effects Beyond the HDL: Clues From Human PON3 Transgenic Mice
Circ. Res., April 27, 2007; 100(8): 1104 - 1105.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. J. Ignarro, M. L. Balestrieri, and C. Napoli
Nutrition, physical activity, and cardiovascular disease: An update
Cardiovasc Res, January 15, 2007; 73(2): 326 - 340.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. de Nigris, S. Williams-Ignarro, V. Sica, L. O. Lerman, F. P. D'Armiento, R. E. Byrns, A. Casamassimi, D. Carpentiero, C. Schiano, D. Sumi, et al.
Effects of a Pomegranate Fruit Extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis
Cardiovasc Res, January 15, 2007; 73(2): 414 - 423.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Ng, N. Bourquard, V. Grijalva, S. Hama, D. M. Shih, M. Navab, A. M. Fogelman, A. J. Lusis, S. Young, and S. T. Reddy
Paraoxonase-2 Deficiency Aggravates Atherosclerosis in Mice Despite Lower Apolipoprotein-B-containing Lipoproteins: ANTI-ATHEROGENIC ROLE FOR PARAOXONASE-2
J. Biol. Chem., October 6, 2006; 281(40): 29491 - 29500.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. S. Carlson, P. J. Heagerty, T. S. Hatsukami, R. J. Richter, J. Ranchalis, J. Lewis, T. J. Bacus, L. A. McKinstry, G. D. Schellenberg, M. Rieder, et al.
TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease
J. Lipid Res., May 1, 2006; 47(5): 1014 - 1024.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. I. Draganov, J. F. Teiber, A. Speelman, Y. Osawa, R. Sunahara, and B. N. La Du
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
J. Lipid Res., June 1, 2005; 46(6): 1239 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. de Nigris, S. Williams-Ignarro, L. O. Lerman, E. Crimi, C. Botti, G. Mansueto, F. P. D'Armiento, G. De Rosa, V. Sica, L. J. Ignarro, et al.
Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress
PNAS, March 29, 2005; 102(13): 4896 - 4901.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Rosenblat, T. Hayek, K. Hussein, and M. Aviram
Decreased Macrophage Paraoxonase 2 Expression in Patients With Hypercholesterolemia Is the Result of Their Increased Cellular Cholesterol Content: Effect of Atorvastatin Therapy
Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 175 - 180.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Rozenberg, D. M. Shih, and M. Aviram
Human Serum Paraoxonase 1 Decreases Macrophage Cholesterol Biosynthesis: Possible Role for Its Phospholipase-A2-Like Activity and Lysophosphatidylcholine Formation
Arterioscler Thromb Vasc Biol, March 1, 2003; 23(3): 461 - 467.
[Abstract] [Full Text] [PDF]